QUANTARIS LIMITED
QUANTARIS LIMITED operates MedDecode, an AI-powered web platform that converts uploaded blood test reports (PDF/JPG/PNG) into plain-language educational explanations for individual consumers, sold via a self-serve credit-based pricing model. The company is a UK-registered private limited company founded in 2025.
- Company typePrivate
- Founded2025
- HeadquartersSt. Leonards-On-Sea, United Kingdom
- Headcount—
- GTM typeB2C
- OfferingSoftware
What QUANTARIS LIMITED does
QUANTARIS LIMITED is a UK-registered private limited company (Company No. 16470876) headquartered at 100 Menzies Road, St. Leonards-On-Sea, England, and was founded in 2025. The company operates a single product, MedDecode, accessible at meddecode.com, which provides an AI-powered web platform that converts uploaded blood test and laboratory reports into plain-language educational explanations for individual consumers rather than clinicians or payers.
The core technology combines document parsing for PDF, JPG, and PNG inputs with natural language generation: users upload a lab report, the system extracts marker values, compares them against established medical reference ranges, and produces educational interpretations alongside suggested follow-up questions for healthcare professionals. The service is delivered under three token-based pricing tiers — Silver (€5 for 10,000 credits, roughly two reports), Gold (€15 for 30,000 credits, roughly six reports), and Platinum (custom credit amount) — with a 5,000-credit minimum per analysis, non-expiring balances, and consumption that scales with document length and follow-up questions. The Terms of Service explicitly disclaim provision of medical advice, diagnosis, or treatment, positioning MedDecode as a pre-appointment educational aid.
Distribution is fully direct-to-consumer through the company's own web application under a self-serve, product-led growth motion. Marketing is limited to organic SEO on the company's content site, Facebook and Instagram brand pages, and an opt-in email newsletter. Data is processed and stored in the EU per the privacy policy, despite the company being UK-incorporated. No funding rounds, no named customers or partners, no management team, and no headcount figures are disclosed in the available source material, and the service appears to be at an early, single-product stage with no disclosed transaction volume.
QUANTARIS LIMITED firmographics
Firmographics- Name
- QUANTARIS LIMITED
- Legal name
- QUANTARIS LIMITED
- Website
- https://meddecode.com
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Short description
- QUANTARIS LIMITED operates MedDecode, an AI-powered web platform that converts uploaded blood test reports (PDF/JPG/PNG) into plain-language educational explanations for individual consumers, sold via a self-serve credit-based pricing model. The company is a UK-registered private limited company founded in 2025.
- Ownership category
- akta.pro rank
QUANTARIS LIMITED industry classification
Industry- Product category
- Consumer Health AI Software
- NAICS
- Information (51)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
- akta.pro secondary industry
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)
Keywords
Where QUANTARIS LIMITED is headquartered
LocationHeadquarters
- HQ city
- St. Leonards-On-Sea
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
QUANTARIS LIMITED business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Infrastructure, Marketing or Sales, Personnel, Operations
Revenue model
- Token/Credit Purchases: Users purchase token packages in advance (Silver Plan at €5 for 10,000 credits, Gold Plan at €15 for 30,000 credits, Platinum with custom amounts). Credits are consumed when uploading reports for analysis, generating follow-up questions, or retrieving extended insights. Each report requires a minimum of 5,000 credits. Tokens do not expire, providing flexibility for occasional users.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Silver Plan - €5 for 10,000 credits (~2 reports) |
| Unit Pricing | Pay-as-you-go | Gold Plan - €15 for 30,000 credits (~6 reports) |
| Unit Pricing | Pay-as-you-go | Platinum Plan - Custom credit amount |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
QUANTARIS LIMITED product offering
Product offeringCore offering
MedDecode is an AI-powered web platform where individual users upload blood test or laboratory results in PDF, JPG, or PNG format and receive plain-language, educational explanations of the markers, reference ranges, and areas potentially requiring attention. The system uses artificial intelligence to extract marker values, compare them against established medical reference points, and generate educational insights along with suggested follow-up questions for a clinician, all delivered on a token-based credit pricing model.
Product overview
QUANTARIS LIMITED operates MedDecode as a single AI-powered SaaS product. The platform consists of a web-based application where users upload blood test reports (supporting PDF, JPG, and PNG formats) and receive AI-generated plain-language educational explanations of their lab results. The service uses a token-based credit system for access, with three subscription tiers (Silver, Gold, Platinum) providing different credit amounts. Key features include instant analysis, reference range comparisons, and follow-up question generation. MedDecode is designed exclusively for educational purposes and explicitly does not provide medical advice, diagnosis, or treatment.
Differentiator
Problem solved
Functional benefit
Products and services
- MedDecode MedDecode is a web-based AI platform that lets individual consumers upload blood test or laboratory reports in PDF, JPG, or PNG formats and receive plain-language, AI-generated educational explanations of markers, reference ranges, and areas potentially requiring attention, along with suggested follow-up questions for clinicians. It is positioned strictly as an educational tool and does not provide medical advice, diagnosis, or treatment.
Companies that use QUANTARIS LIMITED
Customer profileSegments1 record
Ideal customer profiles1 record
QUANTARIS LIMITED technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature4 records
QUANTARIS LIMITED partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights3 records
QUANTARIS LIMITED competitors and assessment
Company assessmentBroad incumbents
- Viome: Viome offers AI-powered health insights from microbiome and other test data for consumers, sharing MedDecode's model of translating complex lab output into actionable consumer-facing explanations.
- Thorne: Thorne is an established supplement and wellness brand that has expanded into at-home testing with biomarker interpretation, representing a broader incumbent with overlapping consumer lab interpretation capabilities.
Direct peers
- Everlywell: Everlywell offers at-home lab testing with results interpretation for consumers, combining testing services with accessible explanations of what results mean — comparable to MedDecode's consumer-facing lab interpretation.
- InsideTracker: InsideTracker offers AI-driven blood test analysis and personalized health recommendations for consumers, with ongoing tracking and biomarker interpretation — directly comparable to MedDecode's lab result interpretation use case.
- Function Health: Function Health provides comprehensive blood testing with AI-powered interpretation and actionable health insights for consumers, representing a more capitalized direct competitor in lab result decoding.
- Levels Health: Levels provides AI-driven metabolic health insights from continuous glucose and lab data, with consumer-friendly interpretation of biomarkers — overlapping with MedDecode's plain-language biomarker explanation model.
- WellnessFX: WellnessFX provides consumer blood test analysis with personalized insights and biomarker tracking, addressing the same pain point as MedDecode around understanding complex lab values.
Emerging players
- Superpower: Superpower is an emerging consumer health platform offering comprehensive lab testing with AI-driven insights and biomarker interpretation — a younger direct competitor pursuing similar territory to MedDecode.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
QUANTARIS LIMITED social profiles
Digital presenceQUANTARIS LIMITED financial estimates
Financial estimateRevenue estimate
Valuation estimate
QUANTARIS LIMITED leadership team
Management profileNumber of profiles
QUANTARIS LIMITED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QUANTARIS LIMITED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QUANTARIS LIMITED
What does QUANTARIS LIMITED do?
MedDecode is an AI-powered web platform where individual users upload blood test or laboratory results in PDF, JPG, or PNG format and receive plain-language, educational explanations of the markers, reference ranges, and areas potentially requiring attention. The system uses artificial intelligence to extract marker values, compare them against established medical reference points, and generate educational insights along with suggested follow-up questions for a clinician, all delivered on a token-based credit pricing model.
Is QUANTARIS LIMITED a public or private company?
QUANTARIS LIMITED is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was QUANTARIS LIMITED founded?
QUANTARIS LIMITED was founded in 2025.
Where is QUANTARIS LIMITED based?
QUANTARIS LIMITED is headquartered in St. Leonards-On-Sea, United Kingdom, in the Europe region.
How does QUANTARIS LIMITED make money?
One revenue line is on record: token/Credit Purchases.
Who are QUANTARIS LIMITED's main competitors?
Broad incumbents on record are Viome and Thorne. Direct peers are Everlywell, InsideTracker, Function Health, Levels Health and WellnessFX. Superpower is listed as an emerging player.
Does QUANTARIS LIMITED have an API?
No public API is recorded for QUANTARIS LIMITED.
What industry is QUANTARIS LIMITED in?
QUANTARIS LIMITED's product category is Consumer Health AI Software. Its primary akta.pro industry code is HLAAALAO, Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 51 and its SIC code is 7372.